1-3 of 3
Manuela Bergmann, MD
Close
Sort by
Journal Articles

Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group

Petra Jenke, Barbara Eichhorst, MD, Raymonde Busch, Nadine Anheier, Ulrich Duehrsen, MD, Jan Duerig, Martin H. Dreyling, PhD, Manuela Bergmann, MD, Maria Elisabeth Goebeler, Hans Juergen Hurtz, Martina Beate Stauch, Stephan Stilgenbauer, MD, Hartmut Doehner, Prof. Dr. med., Anna-Maria Fink, MD, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Michael Hallek, MD
Journal: Blood
Blood (2011) 118 (21): 2860.
https://doi.org/10.1182/blood.V118.21.2860.2860
Published: 2011
Journal Articles

Proposal of A Prognostic Score for Previously Untreated Patients with Chronic Lymphocytic Leukemia Based on An Overall Survival Analysis of Three German CLL Study Group Phase III Trials

Jasmin Bahlo, Natali Pflug, MD, Thomas Elter, MD, Kathrin Bauer, MD, Barbara Eichhorst, MD, Manuela Bergmann, MD, Raymonde Busch, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, Clemens-Martin Wendtner, MD, Kirsten Fischer, MD, Michael Hallek, MD
Journal: Blood
Blood (2011) 118 (21): 2831.
https://doi.org/10.1182/blood.V118.21.2831.2831
Published: 2011
Journal Articles

No Significant Clinical Benefit of First Line Therapy with Fludarabine (F) in Comparison to Chlorambucil (Clb) in Elderly Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Phase III Study of the German CLL Study Group (GCLLSG).

Barbara F. Eichhorst, MD, Raymonde Busch, Martina Stauch, MD, Manuela Bergmann, MD, Matthias Ritgen, MD, Nicole Kranzhöfer, MD, Carmen D. Schweighofer, MD, Kirsten Fischer, MD, Anna-Maria Fink, MD, Paula Cramer, Valentin Goede, MD, Clemens M. Wendtner, MD, Michael Hallek, MD, GCLLSG
Journal: Blood
Blood (2007) 110 (11): 629.
https://doi.org/10.1182/blood.V110.11.629.629
Published: 2007